This program is funded by an independent grant from Takeda. This online education program has been designed solely for healthcare professionals in the USA. The content is not available for healthcare professionals in any other country.
This accredited CME online course is designed for psychiatrists and healthcare professionals to learn the latest updates in Major Depressive Disorder (MDD).
Evidence-based strategies to optimize treatment outcomes for MDD patients
Participants will learn to integrate cutting-edge clinical guidelines and research findings into individualized treatment plans, ensuring optimal patient outcomes. The course covers the application of combination therapies and adjunctive treatments tailored to patient responses and tolerances. Psychiatrists and Healthcare professionals will gain expertise in identifying and managing treatment-resistant aspects of MDD.
Address residual symptoms in MDD
Addressing residual symptoms in MDD is crucial for improving patient quality of life. This course will teach participants to identify and manage symptoms such as cognitive impairment and emotional blunting, incorporating both pharmacological and non-pharmacological approaches.
Patient engagement and education in the management of MDD
Finally, the course emphasizes the importance of patient engagement and education. Participants will learn to communicate effectively, empowering patients to take an active role in their treatment, and develop strategies to improve adherence and self-management across diverse populations.
Who is this course for
This online education program has been designed solely for healthcare professionals in the USA. The course provides continuing education for:
✅ Psychiatrists
✅ Psychiatry Physician Assistants
✅ Psychiatric Nurse Practitioners
✅ Clinical Psychologists
✅ Neurologists
✅ Family Physicians
✅ Physicians
✅ Physician Assistants
✅ Nurse Practitioners
✅ Other Health Professionals
Faculty
Dr Sagar Parikh
Dr. Sagar V. Parikh, MD, FRCPC, is an expert in depression and clinical neuroscience, currently holding the John F. Greden Professorship at the University of Michigan. He also serves as an adjunct Professor of Psychiatry at the University of Toronto. He started his medical career as a primary care physician before completing his Psychiatry residency at the University of Michigan and the University of Toronto. Dr. Parikh's extensive research interests include clinical trials, psychopharmacology, psychotherapy for mood disorders, medical education, epidemiology, biomarkers, interventional psychiatry, and health services. He has co-authored all ten editions of the CANMAT guidelines for depression and bipolar disorder and has published over 200 peer-reviewed articles. A renowned CME presenter and researcher, Dr. Parikh has earned numerous awards for his research and teaching at local, national, and international levels.
Dr Glenda Wrenn Gordon
Dr Glenda Wrenn Gordon is an Associate Professor of Clinical Psychiatry at Morehouse School of Medicine, Medical Director of Clinical Integration at Mindoula, and a member of the NAMI Board of Directors. She is a board-certified adult psychiatrist and a leader in advancing mental health equity. She was the founding director of the Kennedy Satcher Center for Mental Health Equity and has authored numerous publications, including recent work on racial disparities in depression treatment. In 2020, she received the NAMI Psychiatrist of the Year Award.
Dr Adam Meadows
Dr. Adam Meadows is a board-certified psychiatrist with expertise in mood disorders, adult ADHD, and mental health issues. He is Medical Director of Admissions and Adjunct Assistant Professor at Emory University School of Medicine. Dr. Meadows is a member of the American Psychiatric Association and the Georgia Psychiatric Physicians Association. Dr. Meadows completed his psychiatry residency at the University of Pennsylvania, serving as chief resident in his final year. He focuses on leadership development, public speaking, and reducing mental health stigma, aiming to make a positive societal impact.
Faculty, planners, and staff disclosure information
Sagar Parikh has consulted for Sage, Otsuka, and Aifred (software). He has received clinical trial contracts from Sage, Janssen, Compass and Aifred (software). Glenda Wrenn Gordon, Adam Meadows & Jade Brown have no relevant financial or non-financial interests to disclose.
Current Concepts Institute/MedAll staff and the planners and reviewers of this educational activity have no relevant financial or non-financial interests to disclose.
Unapproved and/or off-label use disclosure
Current Concepts Institute/MedAll requires CE faculty to disclose to the participants:
1. When products or procedures being discussed are off-label, unlabelled, experimental, and/or investigational (not US Food and Drug Administration [FDA] approved); and
2. Any limitations on the information presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion.
Accreditation statement
AMA PRA Category 1 Credits™ are available for this activity.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Current Concepts Institute and MedAll Education. Current Concepts Institute is accredited by the ACCME to provide continuing medical education for physicians.
Current Concepts Institute designates this online activity a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity
This continuing education activity is active starting July 8 2024 and will expire on July 8 2025. Estimated time to complete this activity: 1.5 hours.